Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00584233 · ClinicalTrials.gov registry record · NA

Evaluation of Breast CT

A NA study of Breast Cancer, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT00584233: Completed NA study of Breast Cancer, sponsored by University of California, Davis.

NCT00584233 is a NA study of Breast Cancer that has completed, run by University of California, Davis. The registered enrollment target is 75 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00584233, a NA study of Breast Cancer, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The investigators have studied the potential of breast computed tomography (bCT) for breast imaging under an NIH-funded Biomedical Research Partnership (BRP) grant (R01 EB002138-10), and 4 breast CT scanners have been developed that have imaged over 600 women to date (under more than one IRB-approved protocol). The BRP grant cannot be renewed, and with this (resubmitted) R01 grant application, the investigators seek to finalize the investigators' research in breast CT - The specific aims have been significantly modified as a result of the first critique, and the investigators now focus on a narrower set of remaining issues. This version of the protocol will add breast magnetic resonance imaging (MRI) to the experimental procedures.

Primary Outcome

The specific quantitative endpoint of the analysis is the difference in area under the receiver operating characteristic curve (AUC) between contrast-enhanced breast CT (CE-bCT) and contrast-enhanced breast MRI (CE-bMRI).

Conditions Studied

Interventions

  • DEVICE MRI
  • DEVICE computed tomography

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2004-11-22
Est. Completion 2020-03-05
Phase NA
University of California, Davis

657 total trials

What the finished NCT00584233 record still lists

NCT00584233 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT00584233 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00584233 about?

NCT00584233 is a clinical study titled "Evaluation of Breast CT". The investigators have studied the potential of breast computed tomography (bCT) for breast imaging under an NIH-funded Biomedical Research Partnership (BRP) grant (R01 EB002138-10), and 4 breast CT scanners have been developed that have imaged over 600 women to date (under more than one IRB-approve...

What is the current status of trial NCT00584233?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2004-11-22. Estimated completion is 2020-03-05.

What conditions does trial NCT00584233 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00584233?

The interventions under investigation include: MRI (DEVICE), computed tomography (DEVICE).

Who is sponsoring clinical trial NCT00584233?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00584233 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00584233's enrollment target sits among peer trials

75 675th of 1224 higher than 544 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00584233, the US trial registry maintained by the National Library of Medicine. NCT00584233 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.